We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
6
5 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Active, not recruiting
1
16.7%
Not yet recruiting
4
66.7%
Unknown
No approval data available
- WHO declared the Ebola disease outbreak caused by Bundibugyo virus in the DRC and Uganda a Public Health Emergency of International Concern (PHEIC) on May 17, 2026, with 1,406 confirmed cases and 438 deaths reported in the DRC alone. - The WHO added the first molecular diagnostic test for Bundibugyo virus to its Emergency Use Listing, enabling rapid and accurate detection through genetic material identification in blood samples. - Unlike Ebola-Zaire strains, there are currently no approved Bundibugyo virus-specific therapeutics or vaccines, making diagnostic tools and supportive care the primary response measures. - Laboratory testing capacity has expanded from 200–400 tests per day to over 2,000 tests per day across 10 laboratories in affected provinces, supported by WHO and Africa CDC.